We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Tipifarnib in Treating Young Patients With Refractory Leukemia

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00022451
First Posted: January 27, 2003
Last Update Posted: March 15, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
National Cancer Institute (NCI)
Children's Oncology Group
Information provided by:
National Institutes of Health Clinical Center (CC)